MODERN CLINICAL APPROACHES TO GLAUCOMA TREATMENT
Keywords:
Glaucoma, intraocular pressure, optic nerve, selective laser trabeculoplasty, pharmacological therapy, optical coherence tomography, visual field, retinal nerve fiber layer, ophthalmology.Abstract
Glaucoma is one of the leading causes of irreversible blindness worldwide and remains a major challenge in modern ophthalmology. The aim of this study was to evaluate modern clinical approaches to glaucoma treatment and determine their effectiveness in controlling disease progression and preserving visual function. A total of 30 patients with primary open-angle glaucoma participated in the study and were divided into two groups. The first group received conventional pharmacological therapy, while the second group underwent comprehensive treatment consisting of topical medications, selective laser trabeculoplasty, and individualized clinical follow-up. The results demonstrated that the comprehensive treatment approach achieved greater reduction in intraocular pressure, better preservation of the retinal nerve fiber layer, slower progression of visual field defects, and higher patient satisfaction compared with conventional treatment. No serious treatment-related complications were observed during the follow-up period. These findings indicate that modern clinical management combining pharmacological therapy, laser treatment, and regular monitoring provides superior clinical outcomes and contributes to the long-term preservation of visual function in patients with glaucoma.
References
1.Weinreb R.N., Aung T., Medeiros F.A. The Pathophysiology and Treatment of Glaucoma: A Review. JAMA. 2014;311(18):1901–1911.
2.Jonas J.B., Aung T., Bourne R.R.A., Bron A.M., Ritch R., Panda-Jonas S. Glaucoma. The Lancet. 2017;390(10108):2183–2193.
3.European Glaucoma Society. European Glaucoma Society Terminology and Guidelines for Glaucoma. 5th Edition. British Journal of Ophthalmology. 2021;105(Suppl.1):1–169.
4.Stein J.D., Khawaja A.P., Weizer J.S. Glaucoma in Adults—Screening, Diagnosis, and Management. JAMA. 2021;325(2):164–174.
5.Weinreb R.N., Garway-Heath D.F., Leung C.K.S., Medeiros F.A. Diagnosis and Monitoring of Glaucoma. Amsterdam: Elsevier; 2022.
6.Gedde S.J., Vinod K., Wright M.M., et al. Primary Open-Angle Glaucoma Preferred Practice Pattern®. Ophthalmology. 2021;128(1)–P150.
7.Lim R., Rong S.S., Lee J.W.Y., et al. Artificial Intelligence in Glaucoma: Current Applications and Future Perspectives. Eye. 2022;36(9):1721–1732.
8.Chen X., Xu Y., Chen H., et al. Advances in Optical Coherence Tomography for Glaucoma Diagnosis and Monitoring. Journal of Clinical Medicine. 2023;12(8):2857.
9.Baudouin C., Kolko M., Melik-Parsadaniantz S., Messmer E.M. Inflammation in Glaucoma: From Pathogenesis to Therapeutic Perspectives. Progress in Retinal and Eye Research. 2023;94:101134.
10.Prum B.E., Rosenberg L.F., Gedde S.J., et al. Primary Open-Angle Glaucoma Preferred Practice Pattern®. Ophthalmology. 2024;131(2)–e128.




United Kingdom
Germany
France
Uzbekistan
Türkiye
Kazakhstan
Kyrgyzstan
Turkmenistan
Azerbaijan
India
Republic of Korea
Japan
United States of America
Kosovo
Italy
Spain
Poland
Netherlands
Belgium
Sweden
Norway
Finland
Denmark
Switzerland
Austria
Czech Republic
Hungary
Romania
Bulgaria
Greece
Portugal